AVTX: Avalo Therapeutics, Inc Company Short-Term Debt
The price action of Avalo Therapeutics, Inc (AVTX) on the GURU.Markets platform reflects the dynamics of a company developing immune-boosting agents, where the indicator stands at 0.00. Massive R&D expenditures and rigorous synthesis quality control create significant barriers to entry for competitors. Meanwhile, a strategic shift toward early-stage trials renders the asset speculative, posing a liquidity shortage risk absent new offerings or partnerships.
Metric breakdowns and analytics for Avalo Therapeutics Inc (AVTX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Avalo Therapeutics, Inc|AVTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Avalo Therapeutics, Inc|AVTX - Company Total Debt|Debt to Book Capitalization Ratio Avalo Therapeutics, Inc.|AVTX - Company Long-Term Liabilities|Company Current Liabilities Avalo Therapeutics|Quick Liquidity avalotx.com
- net income and valuation multiples indicators:
Initial company analysis:AVTX - Avalo Therapeutics
Avalo Therapeutics, Inc (AVTX) ensures stable supplies of biologics for the therapy of immune pathologies through logistics diversification. This indicator captures the total value of loans due for payment within the next twelve months. By analyzing the volume of short-term liabilities, one can track current liquidity trends without reporting distortions. An increase in this metric signals a risk of funding shortages for raw material procurement. Monitoring this metric allows for an assessment of operational resilience against cash flow gaps.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|IMNM (Immunome, Inc.) - Company Current Liabilities|GOSS (gossamerbio.com) - Company Short-Term Debt|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts Septerna, Inc.|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Company Short-Term Debt SVRA (Savara Pharma)|Company Short-Term Debt Rigel Pharmaceuticals RIGL|anaptysbio.com (ANAB) - Short-Term Debt|ATXS: Company Current Liabilities|Company Short-Term Loans and Borrowings ENGN (enGene Holdings Inc)|RAPT (RAPT Therapeutics) - Company Current Liabilities|JBIO: Amount of Current Liabilities|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|KYTX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TLSA|CABA - Short-Term Debt|Company Short-Term Debt Ventyx Bio VTYX|Company Short-Term Loans and Borrowings THTX|Eledon Pharmaceuticals - Company Short-Term Debts|AGEN - Company Short-Term Debts|Climb Bio (CLYM) - Company Short-Term Debt|Current Liabilities ZURA (zurabio.com)|ATYR (aTyr) - Company Short-Term Debts|Short-Term Debt Adagene Corp ADAG|Company Current Liabilities IMA (ImageneBio Inc)|Company Short-Term Debts shattucklabs.com (STTK)|Equillium - Company Current Liabilities|Amount of Current Liabilities CNTB (Connect Biopharma Holdings)|Immunic Inc - Company Short-Term Debts|Short-Term Debt Volume Atara Biotherapeutics ATRA|IFRX: Company Short-Term Debts|Company Current Liabilities x4pharma.com|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp (CELU) - Short-Term Debt Volume|Company Current Liabilities INMB (INmune Bio Corp)|BRNS (Barinthus Biotherapeutics Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts KZR (Kezar Life Sciences)|Short-Term Debt Volume sabbiotherapeutics.com (SABS)|AKTX - Company Short-Term Debt|ENLV (Enlivex Therapeutics) - Company Short-Term Indebtedness|QTTB: Company Short-Term Debts|Company Current Liabilities GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Short-Term Debts ibioinc.com|Company Current Liabilities CARM (Carisma Therapeutics)|Company Short-Term Debt XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Current Liabilities|Amount of Current Liabilities HCWB (HCW Biologics, Inc.)|APVO: Company Current Liabilities|AIM (aimimmuno.com) - Company Short-Term Indebtedness|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc